| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 275,000 | 14 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SABS | SAB Biotherapeutics, Inc. | 14 Mar 2023 | 1 | $0 | 4 | Chief Financial Officer | 16 Mar 2023, 16:27 |
| SABS | SAB Biotherapeutics, Inc. | 13 Sep 2022 | 1 | $0 | 4 | CHIEF FINANCIAL OFFICER | 15 Sep 2022, 16:45 |
| SABS | SAB Biotherapeutics, Inc. | 16 Mar 2022 | 1 | $0 | 4 | Chief Financial Officer | 18 Mar 2022, 21:15 |
| SABS | SAB Biotherapeutics, Inc. | 17 Nov 2021 | 1 | $0 | 4 | Chief Financial Officer | 19 Nov 2021, 15:45 |
| SABS | Big Cypress Acquisition Corp. | 22 Oct 2021 | 0 | $0 | 3 | Chief Financial Officer | 22 Oct 2021, 21:22 |
| SABS | SAB Biotherapeutics, Inc. | 18 Oct 2021 | 6 | +$25,458 | 4 | Chief Financial Officer | 16 Nov 2021, 14:09 |